Venus Remedies Limited (NSE:VENUSREM)
India
· Delayed Price · Currency is INR 429.00
-6.60 (-1.52%)
Jun 6, 2025, 3:30 PM IST
Venus Remedies Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 800.8 | 489.56 | 212.12 | 432.56 | 288.79 | Upgrade
|
| Short-Term Investments | 840.9 | 348.49 | 508.65 | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,642 | 838.05 | 720.77 | 432.56 | 288.79 | Upgrade
|
| Cash Growth | 95.90% | 16.27% | 66.63% | 49.78% | 1386.78% | Upgrade
|
| Accounts Receivable | 1,122 | 804.98 | 766.6 | 386 | 320.42 | Upgrade
|
| Other Receivables | 108.6 | 299.35 | 301.75 | 326.94 | 333.84 | Upgrade
|
| Receivables | 1,231 | 1,110 | 1,069 | 716.14 | 656.32 | Upgrade
|
| Inventory | 1,005 | 1,217 | 1,199 | 1,256 | 1,200 | Upgrade
|
| Prepaid Expenses | - | 6.34 | 6.74 | 4.98 | 5.02 | Upgrade
|
| Other Current Assets | 639.8 | 424.36 | 232.63 | 370.28 | 190.33 | Upgrade
|
| Total Current Assets | 4,517 | 3,595 | 3,228 | 2,780 | 2,340 | Upgrade
|
| Property, Plant & Equipment | 1,511 | 1,544 | 1,628 | 1,782 | 1,901 | Upgrade
|
| Long-Term Investments | 0.2 | 0.18 | - | - | - | Upgrade
|
| Other Intangible Assets | 1,047 | 852.11 | 792.46 | 879.29 | 967.16 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 6.82 | - | Upgrade
|
| Other Long-Term Assets | 81.7 | 276.64 | 361.85 | 349.27 | 350.28 | Upgrade
|
| Total Assets | 7,157 | 6,268 | 6,011 | 5,798 | 5,559 | Upgrade
|
| Accounts Payable | 918.6 | 441.44 | 508.4 | 501.67 | 713.57 | Upgrade
|
| Accrued Expenses | 113.5 | 175.57 | 134.67 | 167.7 | 123.95 | Upgrade
|
| Short-Term Debt | 16.9 | 26.46 | 36.14 | 40.64 | 43.05 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 1.02 | 1.82 | Upgrade
|
| Other Current Liabilities | 333.9 | 150.69 | 146.49 | 216.36 | 92.06 | Upgrade
|
| Total Current Liabilities | 1,383 | 794.16 | 825.7 | 927.39 | 974.45 | Upgrade
|
| Long-Term Debt | - | 386.79 | 386.79 | 386.79 | 468.31 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 155.8 | 109.19 | 106.49 | - | 36.34 | Upgrade
|
| Other Long-Term Liabilities | 9 | 24.98 | 22.69 | 27.49 | 28.62 | Upgrade
|
| Total Liabilities | 1,548 | 1,393 | 1,407 | 1,394 | 1,556 | Upgrade
|
| Common Stock | 133.7 | 133.67 | 133.67 | 133.67 | 123.42 | Upgrade
|
| Additional Paid-In Capital | - | 883.28 | 883.28 | 883.28 | 756.01 | Upgrade
|
| Retained Earnings | - | 3,819 | 3,536 | 3,275 | 2,865 | Upgrade
|
| Comprehensive Income & Other | 5,476 | 39.61 | 50.5 | 112.64 | 258.21 | Upgrade
|
| Shareholders' Equity | 5,610 | 4,876 | 4,603 | 4,404 | 4,003 | Upgrade
|
| Total Liabilities & Equity | 7,157 | 6,268 | 6,011 | 5,798 | 5,559 | Upgrade
|
| Total Debt | 16.9 | 413.25 | 422.93 | 428.45 | 513.18 | Upgrade
|
| Net Cash (Debt) | 1,625 | 424.8 | 297.84 | 4.11 | -224.39 | Upgrade
|
| Net Cash Growth | 282.49% | 42.63% | 7153.70% | - | - | Upgrade
|
| Net Cash Per Share | 121.54 | 31.78 | 22.28 | 0.31 | -18.18 | Upgrade
|
| Filing Date Shares Outstanding | 13.37 | 13.37 | 13.37 | 13.37 | 12.34 | Upgrade
|
| Total Common Shares Outstanding | 13.37 | 13.37 | 13.37 | 13.37 | 12.34 | Upgrade
|
| Working Capital | 3,134 | 2,801 | 2,403 | 1,853 | 1,366 | Upgrade
|
| Book Value Per Share | 419.64 | 364.74 | 344.38 | 329.50 | 324.33 | Upgrade
|
| Tangible Book Value | 4,562 | 4,023 | 3,811 | 3,525 | 3,036 | Upgrade
|
| Tangible Book Value Per Share | 341.30 | 300.99 | 285.10 | 263.72 | 245.96 | Upgrade
|
| Land | - | 117.54 | 114.04 | - | - | Upgrade
|
| Buildings | - | 1,011 | 925 | - | - | Upgrade
|
| Machinery | - | 2,425 | 2,510 | - | - | Upgrade
|
| Construction In Progress | - | 210.84 | 260.98 | 252.33 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.